GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
June 06, 2026
June 06, 2026
DALLAS, Texas, June 6 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
*
Research Highlights:
* Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality.
* The . . .
* * *
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
*
Research Highlights:
* Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality.
* The . . .